Wednesday  July 01  2015
Text Size


Research for Pipeline Review, H1 2012

Remarkable News

“2012-2016” Latest News : MarketAark :Research for Pipeline Review, H1 2012

Influenza – Pipeline Review, H1 2012

Browse for More Related Reports (Pipeline Review, H1 2012) through below Link : -,%20H1%202012&PubId=&pagenum=1


Company's Influenza Pipeline Review, H1 2012, provides an overview of the Influenza therapeutic pipeline. This report provides information on the therapeutic development for Influenza, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Influenza. Influenza Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


A snapshot of the global therapeutic scenario for Influenza.
A review of the Influenza products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Coverage of products based on various stages of development ranging from discovery till registration stages.
A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Coverage of the Influenza pipeline on the basis of route of administration and molecule type.
Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
Key discontinued pipeline projects.
Latest news and deals relating to the products. etc.,